Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Total Assets history
Currency unavailable · from the balance sheet
No Total Assets data reported for this period type.
Total Assets vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | $1.92B USD | +57.0% | +12.0% | |
| Jun 2026 | $704.45M USD | -13.6% | +17.1% | |
| Mar 2026 | $292.36M USD | — | — | |
| Mar 2026 | $173.33M USD | +83.8% | +93.7% | |
| Mar 2026 | $135.07M USD | -6.2% | -19.2% | |
| — | — | — | — | |
| Peer median (excluding KARD) | — | +25.4% | +14.6% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.